Antimicrobial agents | Number (%) of resistant isolates | ||
---|---|---|---|
ESBL (n = 31) | Non-ESBL (n = 121) | Total (n = 152) | |
Amoxicillin | 31 (100) | 121 (100) | 152 (100) |
Amoxicillin/clavulanic acid | 31 (100) | 115 (95) | 146 (96) |
Piperacillin | 31 (100) | 99 (81.81) | 130 (85.52) |
Piperacillin/tazobactam | 24 (77.44) | 52 (42.97) | 76 (50) |
Cefoxitin | 22(70.3) | 87 (71.1) | 109 (71.7) |
Ceftazidime | 31 (100) | 2 (1.65) | 33 (21.71) |
Cefotaxime | 31 (100) | 3 (2.47) | 34 (22.36) |
Cefepime | 31 (100) | 2 (1.65) | 33 (21.71) |
Aztreonam | 31 (100) | 2 (1.65) | 33 (21.71) |
Imipenem | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Meropenem | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Ciprofloxacin | 30 (96.77) | 49 (40.5) | 79 (51.97) |
Gentamicin | 26 (83.87) | 37 (30.58) | 63 (41.44) |
Amikacin | 17 (54.38) | 25 (20.66) | 42 (27.63) |
Colistin | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Tigecycline | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Fosfomycin | 0 (0.0) | 0 (0.0) | 0 (0.0) |